Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa6e24f035c87ed5556b6cb2b0698500 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6503 |
filingDate |
2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb8022830fd78f13f7a202e956fef27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1495e4d5d761e500c8b402931ea35edf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4e4c58963066abb776879300d96f2bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4ebfa9a5df1ba3370a300a1a4e99d32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e6b92b94cd644cf3e35a211fed0999d |
publicationDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2016219653-B2 |
titleOfInvention |
Crystallization Method and Bioavailability |
abstract |
CRYSTALLIZATION METHOD AND BIOAVAILABILITY Preparation and in vitro and in vivo characterization of novel forms of active pharmaceutical ingredients, suitable for pharmaceutical compositions in drug delivery systems for humans is disclosed. |
priorityDate |
2010-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |